Steve Offer on Characterizing Potential Biomarkers of Colorectal Cancer Using xCELLigence & NovoCyte

At the 31st Congress of the International Society for Advancement of Cytometry (CYTO 2016) in Seattle, Steve Offer, Assistance Professor of Pharmacology, Mayo School of Medicine, discussed how they leveraged the throughput and sensitivity of xCELLigence® RTCA and NovoCyte® flow cytometer technologies to test specific parameters of candidate metastasis-associated signatures identified in his lab.

Steve discussed the correlation between changes in the epigenetic landscape, microRNA expression, gene expression, and how these changes affect tumor progression.